UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:UHS - US9139031002 - Common Stock
218.02 USD
-7.04 (-3.13%)
218.02 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to UHS. UHS was compared to 101 industry peers in the Health Care Providers & Services industry. While UHS has a great profitability rating, there are some minor concerns on its financial health. UHS is valued quite cheap, while showing a decent growth score. This is a good combination! This makes UHS very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year UHS was profitable.
UHS had a positive operating cash flow in the past year.
In the past 5 years UHS has always been profitable.
In the past 5 years UHS always reported a positive cash flow from operatings.
1.2 Ratios
UHS has a better Return On Assets (8.96%) than 92.08% of its industry peers.
The Return On Equity of UHS (19.18%) is better than 86.14% of its industry peers.
UHS has a better Return On Invested Capital (12.33%) than 87.13% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UHS is in line with the industry average of 9.58%.
The last Return On Invested Capital (12.33%) for UHS is above the 3 year average (8.28%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROIC | 12.33% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
1.3 Margins
UHS has a Profit Margin of 8.09%. This is amongst the best in the industry. UHS outperforms 88.12% of its industry peers.
UHS's Profit Margin has been stable in the last couple of years.
UHS has a Operating Margin of 11.47%. This is amongst the best in the industry. UHS outperforms 80.20% of its industry peers.
UHS's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A |
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UHS is still creating some value.
The number of shares outstanding for UHS has been reduced compared to 1 year ago.
Compared to 5 years ago, UHS has less shares outstanding
Compared to 1 year ago, UHS has an improved debt to assets ratio.
2.2 Solvency
UHS has an Altman-Z score of 3.22. This indicates that UHS is financially healthy and has little risk of bankruptcy at the moment.
UHS's Altman-Z score of 3.22 is fine compared to the rest of the industry. UHS outperforms 68.32% of its industry peers.
The Debt to FCF ratio of UHS is 4.84, which is a neutral value as it means it would take UHS, 4.84 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of UHS (4.84) is better than 66.34% of its industry peers.
UHS has a Debt/Equity ratio of 0.55. This is a neutral value indicating UHS is somewhat dependend on debt financing.
UHS has a Debt to Equity ratio (0.55) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Altman-Z | 3.22 |
ROIC/WACC1.48
WACC8.31%
2.3 Liquidity
UHS has a Current Ratio of 1.03. This is a normal value and indicates that UHS is financially healthy and should not expect problems in meeting its short term obligations.
UHS has a Current ratio of 1.03. This is in the lower half of the industry: UHS underperforms 71.29% of its industry peers.
A Quick Ratio of 0.96 indicates that UHS may have some problems paying its short term obligations.
UHS has a worse Quick ratio (0.96) than 68.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
UHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.07%, which is quite impressive.
UHS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.74% yearly.
UHS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.21%.
UHS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.82% yearly.
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
3.2 Future
The Earnings Per Share is expected to grow by 13.53% on average over the next years. This is quite good.
Based on estimates for the next years, UHS will show a small growth in Revenue. The Revenue will grow by 4.90% on average per year.
EPS Next Y32.21%
EPS Next 2Y19.65%
EPS Next 3Y16.81%
EPS Next 5Y13.53%
Revenue Next Year10.55%
Revenue Next 2Y7.74%
Revenue Next 3Y6.89%
Revenue Next 5Y4.9%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.48 indicates a reasonable valuation of UHS.
UHS's Price/Earnings ratio is rather cheap when compared to the industry. UHS is cheaper than 88.12% of the companies in the same industry.
UHS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.51.
A Price/Forward Earnings ratio of 9.15 indicates a reasonable valuation of UHS.
92.08% of the companies in the same industry are more expensive than UHS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of UHS to the average of the S&P500 Index (23.13), we can say UHS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.48 | ||
| Fwd PE | 9.15 |
4.2 Price Multiples
UHS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. UHS is cheaper than 81.19% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UHS is valued a bit cheaper than 76.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.07 | ||
| EV/EBITDA | 7.31 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UHS has a very decent profitability rating, which may justify a higher PE ratio.
UHS's earnings are expected to grow with 16.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)0.98
EPS Next 2Y19.65%
EPS Next 3Y16.81%
5. Dividend
5.1 Amount
With a yearly dividend of 0.35%, UHS is not a good candidate for dividend investing.
UHS's Dividend Yield is a higher than the industry average which is at 0.60.
Compared to an average S&P500 Dividend Yield of 2.00, UHS's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
5.2 History
On average, the dividend of UHS grows each year by 6.27%, which is quite nice.
UHS has paid a dividend for at least 10 years, which is a reliable track record.
UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
5.3 Sustainability
3.78% of the earnings are spent on dividend by UHS. This is a low number and sustainable payout ratio.
UHS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP3.78%
EPS Next 2Y19.65%
EPS Next 3Y16.81%
218.02
-7.04 (-3.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.46%
Inst Owner Change-2.28%
Ins Owners5.68%
Ins Owner Change16.62%
Market Cap13.62B
Revenue(TTM)16.99B
Net Income(TTM)1.38B
Analysts71.54
Price Target254.83 (16.88%)
Short Float %3.96%
Short Ratio2.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP3.78%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.07%
Min EPS beat(2)7.62%
Max EPS beat(2)16.52%
EPS beat(4)4
Avg EPS beat(4)12.73%
Min EPS beat(4)7.62%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)13.14%
EPS beat(12)12
Avg EPS beat(12)10.1%
EPS beat(16)14
Avg EPS beat(16)6.62%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.18%
Max Revenue beat(2)2.44%
Revenue beat(4)3
Avg Revenue beat(4)0.48%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)7
Avg Revenue beat(8)0.45%
Revenue beat(12)9
Avg Revenue beat(12)0.29%
Revenue beat(16)13
Avg Revenue beat(16)0.58%
PT rev (1m)2.24%
PT rev (3m)14.5%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)4.21%
EPS NY rev (1m)2.76%
EPS NY rev (3m)6.09%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)1.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.48 | ||
| Fwd PE | 9.15 | ||
| P/S | 0.8 | ||
| P/FCF | 14.07 | ||
| P/OCF | 6.99 | ||
| P/B | 1.9 | ||
| P/tB | 4.28 | ||
| EV/EBITDA | 7.31 |
EPS(TTM)20.8
EY9.54%
EPS(NY)23.82
Fwd EY10.93%
FCF(TTM)15.5
FCFY7.11%
OCF(TTM)31.18
OCFY14.3%
SpS271.97
BVpS114.75
TBVpS50.9
PEG (NY)0.33
PEG (5Y)0.98
Graham Number231.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROCE | 16% | ||
| ROIC | 12.33% | ||
| ROICexc | 12.44% | ||
| ROICexgc | 18.59% | ||
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A | ||
| FCFM | 5.7% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexgc growth 3Y1.9%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 162.72% | ||
| Cap/Sales | 5.77% | ||
| Interest Coverage | 15.36 | ||
| Cash Conversion | 76.35% | ||
| Profit Quality | 70.41% | ||
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 3.22 |
F-Score8
WACC8.31%
ROIC/WACC1.48
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
EPS Next Y32.21%
EPS Next 2Y19.65%
EPS Next 3Y16.81%
EPS Next 5Y13.53%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
Revenue Next Year10.55%
Revenue Next 2Y7.74%
Revenue Next 3Y6.89%
Revenue Next 5Y4.9%
EBIT growth 1Y26.53%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year60.74%
EBIT Next 3Y20.8%
EBIT Next 5YN/A
FCF growth 1Y135.27%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y75.09%
OCF growth 3Y32.75%
OCF growth 5Y7.52%
UNIVERSAL HEALTH SERVICES-B / UHS FAQ
What is the fundamental rating for UHS stock?
ChartMill assigns a fundamental rating of 6 / 10 to UHS.
Can you provide the valuation status for UNIVERSAL HEALTH SERVICES-B?
ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.
What is the profitability of UHS stock?
UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.
What is the financial health of UNIVERSAL HEALTH SERVICES-B (UHS) stock?
The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10.
How sustainable is the dividend of UNIVERSAL HEALTH SERVICES-B (UHS) stock?
The dividend rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10 and the dividend payout ratio is 3.78%.